Showing all 2 results
Everolimus Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Antioxidant-Stabilized Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the highly oxidative, potent API.
Active Ingredient Strength Primary Clinical Function Everolimus USP/Ph.Eur. 0.25 mg / 0.5 mg / 0.75 mg Global Transplant Standard: Ultra-micro doses utilized for strict, lifelong immunosuppression following renal or hepatic allografts. Requires extreme content uniformity to maintain the narrow therapeutic blood trough levels (3 to 8 ng/mL). Everolimus USP/Ph.Eur. 5 mg / 10 mg Global Oncology Standard: Massive-dose antineoplastic payload utilized for the aggressive suppression of Renal Cell Carcinoma, Neuroendocrine Tumors (NETs), and HR+/HER2- Breast Cancer. Excipients Butylated Hydroxytoluene (BHT) / Hypromellose / Lactose Anhydrous / Crospovidone / Magnesium Stearate Antioxidant / Binder / Diluent / Superdisintegrant / Lubricant (Engineered specifically utilizing BHT (Butylated Hydroxytoluene) to prevent the rapid oxidative degradation of the Everolimus molecule, guaranteeing maximum clinical shelf-life and potency across harsh climates) *Pack Sizes: 10×10 Alu-Alu Blisters (Transplant) or 3×10 Alu-Alu Blisters (Oncology – 30 Day Supply).
Triamcinolone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips to preserve the integrity of the steroidal API across high-humidity tropical climates.
Active Ingredient Strength Primary Clinical Use Triamcinolone IP/USP/BP 4 mg Standard Clinical Dose: Maintenance and flare-reduction therapy for severe inflammatory, allergic, and autoimmune disorders. Excipients Lactose Monohydrate / Magnesium Stearate / Microcrystalline Cellulose Diluent / Lubricant (Engineered for optimal compressibility and rapid gastric dispersion)
